IL13 and glioblastoma: Hegde et al. created a tandem CAR by joining an anti-human epidermal growth factor receptor-2 (HER2) scFv and an IL-13 receptor α2 (IL-13Rα2)-binding IL-13 for the treatment of glioblastoma [65].